238 related articles for article (PubMed ID: 31243104)
1. Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients.
Goebel C; Louden CL; McKenna R; Onugha O; Wachtel A; Long T
Cancer Genomics Proteomics; 2019; 16(4):229-244. PubMed ID: 31243104
[TBL] [Abstract][Full Text] [Related]
2. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
[TBL] [Abstract][Full Text] [Related]
3. Screening and staging for non-small cell lung cancer by serum laser Raman spectroscopy.
Wang H; Zhang S; Wan L; Sun H; Tan J; Su Q
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Aug; 201():34-38. PubMed ID: 29729529
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis.
Yu L; Tao G; Zhu L; Wang G; Li Z; Ye J; Chen Q
BMC Cancer; 2019 May; 19(1):464. PubMed ID: 31101024
[TBL] [Abstract][Full Text] [Related]
5. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
6. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening.
Dominioni L; Imperatori A; Rovera F; Ochetti A; Torrigiotti G; Paolucci M
Cancer; 2000 Dec; 89(11 Suppl):2334-44. PubMed ID: 11147608
[TBL] [Abstract][Full Text] [Related]
7. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
8. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
9. Natural history of stage I non-small cell lung cancer: implications for early detection.
Raz DJ; Zell JA; Ou SH; Gandara DR; Anton-Culver H; Jablons DM
Chest; 2007 Jul; 132(1):193-9. PubMed ID: 17505036
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
11. Detection of lung cancer in silicosis patients using a tumor-marker panel.
Schneider J
Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
[TBL] [Abstract][Full Text] [Related]
12. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
13. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.
Shen S; Zhang R; Guo Y; Loehrer E; Wei Y; Zhu Y; Yuan Q; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Su L; Chen F; Christiani DC
Mol Oncol; 2018 Jun; 12(6):913-924. PubMed ID: 29656435
[TBL] [Abstract][Full Text] [Related]
14. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
Rice SR; Molitoris JK; Vyfhuis MAL; Edelman MJ; Burrows WM; Feliciano J; Nichols EM; Suntharalingam M; Donahue J; Carr SR; Friedberg J; Badiyan S; Simone CB; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2019 Jan; 20(1):e107-e114. PubMed ID: 30337268
[TBL] [Abstract][Full Text] [Related]
15. [The connection between delayed diagnosis of lung cancer and the intraoperative stage].
Christensen ED; Harvald TB; Jendresen M; Aggestrup S; Petterson G
Ugeskr Laeger; 1999 Mar; 161(12):1762-5. PubMed ID: 10210977
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Circulating CXC Chemokines in Non-small Cell Lung Cancer.
Spaks A; Jaunalksne I; Spaka I; Chudasama D; Pirtnieks A; Krievins D
Anticancer Res; 2015 Dec; 35(12):6979-83. PubMed ID: 26637925
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
18. Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer.
Morris S; Vachani A; Pass HI; Rom WN; Ryden K; Weiss GJ; Hogarth DK; Runger G; Richards D; Shelton T; Mallery DW
Int J Cancer; 2018 Jun; 142(11):2355-2362. PubMed ID: 29313979
[TBL] [Abstract][Full Text] [Related]
19. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
[TBL] [Abstract][Full Text] [Related]
20. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
